Not yet recruiting NCT06808698
A Study of the Intestinal Microbiome in Patients with Cirrhosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Determine the gut microbiome at baseline and 12 months..
- Who it may be relevant to
- Registry conditions: Liver Cirrhosis. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aims to establish a cohort for analyzing the gut microbiome of patients with liver cirrhosis and to identify factors that influence the prognosis of these patients.
Interventions
- Other Determine the gut microbiome at baseline and 12 months.
There is no separate treatment, surgery, or other intervention.
Primary outcome measures
- Incidence rate of non-targeted complications according to changes in the gut microbiome [Time frame: baseline, Month 12]
Secondary outcome measures (1)
- Liver cancer incidence rate according to gut microbiome composition [Time frame: Baseline, 12 Month]
Eligibility criteria
Inclusion criteria
- Aged 19 years or older:
- Patients visiting the hospital with liver cirrhosis.
- Patients diagnosed with liver cirrhosis who can understand the information provided to them or their representatives and have voluntarily given written consent to participate in this study
Exclusion criteria
- Cases not meeting the inclusion criteria
- Patients who refuse participation
- Patients who have taken or been administered antibiotics within the past 2 weeks or are scheduled to take or receive antibiotics during the study period
- Cases where the diagnosis is unclear
- Cases with incomplete data or missing investigation items
- Individuals deemed unsuitable by the principal investigator for other reasons
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06808698 · IIT_MicroB